You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
Baxter
Medtronic
Harvard Business School
Johnson and Johnson

Last Updated: February 24, 2020

DrugPatentWatch Database Preview

Litigation Details for MERCK, SHARP & DOHME CORP. v. HETERO USA INC. (D.N.J. 2013)


Email this page to a colleague

See Plans and Pricing

« Back to Dashboard

MERCK, SHARP & DOHME CORP. v. HETERO USA INC. (D.N.J. 2013)

Docket   Start Trial Date Filed 2013-03-07
Court District Court, D. New Jersey Date Terminated 2013-09-20
Cause 35:271 Patent Infringement Assigned To Jerome B. Simandle
Jury Demand None Referred To Ann Marie Donio
Parties BRISTOL-MYERS SQUIBB COMPANY; BRISTOL-MYERS SQUIBB PHARMA CO.; HETERO LABS LIMITED UNIT-III; HETERO USA INC.; MERCK, SHARP & DOHME CORP.
Patents 6,639,071; 6,939,964
Attorneys GAIL L. GOTTEHRER; LIZA M. WALSH; RUKHSANAH L. SINGH; TRICIA B. O'REILLY
Link to Docket External link to docket
Small Molecule Drugs cited in MERCK, SHARP & DOHME CORP. v. HETERO USA INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for MERCK, SHARP & DOHME CORP. v. HETERO USA INC. (D.N.J. 2013)

Date Filed Document No. Description Snippet Link To Document
2013-03-07 1 THE PATENTS 12. United States Patent No. 6,639,071 (“the ‘071 Patent”), entitled … Declaratory Judgment of Patent Infringement of U.S. Patent No. 6,639,071 34. Plaintiffs… Infringement of U.S. Patent No. 6,639,071 22. Plaintiffs repeat and re-allege…Steven D. Young. The ‘964 Patent claims priority to the ‘071 Patent. The ‘964 Patent was assigned to Merck…the ‘964 Patent, and the right to sue for infringement of the ‘964 Patent. The ‘964 Patent is also listed External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Dow
Harvard Business School
Baxter
Boehringer Ingelheim
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.